Sarah Kiely

Sarah is Vice President of Investor Relations and Corporate Communications and has 20 years of healthcare-related and communications experience. She joined ProQR in 2019 from ImmunoGen, Inc. where she was most recently Director, Investor Relations and Corporate Communications. Prior to ImmunoGen, Sarah developed marketing strategies and managed communications at the Dana-Farber Cancer Institute in Boston. There she was responsible for internal and external communications related to the hematologic oncology treatment center and stem cell transplant programs, spanning referring physician outreach, donor communications, community outreach, and patient education. Earlier in her career, Sarah also spent a number of years working with an agency that focused on pharmaceutical sales training. Sarah received an MBA from Boston University and holds a Bachelor’s degree from Boston College.